Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film.
The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan launches generic sublingual film for opioid dependence appeared first on MassDevice. (Source: Mass Device)
Mylan launches generic sublingual film for opioid dependence
Previous post: U.S. top court rejects bid to block Indivior opioid drug copycat
Next post: New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence
